×

Arcadia Biosciences Announces Kevin Comcowich Will Chair Board of Directors

DAVIS, Calif.--(BUSINESS WIRE)-- Arcadia Biosciences, Inc. (Nasdaq: RKDA), an agricultural technology company, announced today that Kevin Comcowich has been elected to chair the board of directors, replacing George Gosbee who passed away last week.

Comcowich joined the Arcadia board as an independent director in 2016 and previously served as chair of the audit committee. He most recently served as the chief executive officer and portfolio manager of HTX Energy Fund in Houston, Texas. He is the former president and chief investment officer (CIO) of Sound Energy Partners and served as CIO and research analyst for Southport Energy Plus Partners fund. Comcowich received his MBA from the University of Indiana and earned his bachelor’s degree from the College of the Holy Cross.

“While I’m saddened by the loss of a good friend and colleague, I look forward to working with my fellow board members and Arcadia’s executive team to capitalize on the many opportunities the company has going forward,” said Comcowich.

The board also appointed Gregory Waller to chair the audit committee and Amy Yoder to chair the compensation committee.

About Arcadia Biosciences, Inc.

Based in Davis, Calif., Arcadia Biosciences (Nasdaq: RKDA) develops agricultural products that create added value for farmers, enhance human health and improve the environmental sustainability of agriculture. Arcadia’s nutrition traits and products are aimed at creating healthier ingredients and whole foods with lower production costs. Arcadia’s agronomic performance traits, including Nitrogen Use Efficiency, Water Use Efficiency, Salinity Tolerance, Heat Tolerance and Herbicide Tolerance, are all aimed at making agricultural production more economically efficient and environmentally sound. For more information, visit www.arcadiabio.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20171121005345/en/

Arcadia Biosciences, Inc.
Jeff Bergau, +1-312-217-0419
jeff.bergau@arcadiabio.com

Source: Arcadia Biosciences, Inc.